Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Inolimomab

EU orphan designation number: EU/3/01/028   
Active ingredient: Inolimomab
Indication: Treatment of Graft versus Host Disease
Sponsor: Jazz Pharmaceuticals France SAS
City One, 84 Quai Charles de Gaulle, 69006 Lyon, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/03/2001 Orphan designation EMEA/OD/038/00 (2001)488 of 05/03/2001
20/07/2004 Change of name and/or address of sponsor
22/01/2008 Change of name and/or address of sponsor
30/09/2016 Change of name and/or address of sponsor